Health Care & Life Sciences » Biotechnology | RenovaCare Inc.

RenovaCare Inc. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cost of Goods Sold (COGS) incl. D&A
-
-
-
0.10
0.30
0.30
Gross Income
-
-
-
0.10
0.30
0.30
SG&A Expense
628.50
2,131.40
1,318.50
1,898.20
2,695.50
2,007.70
EBIT
628.50
2,131.40
1,318.50
1,898.20
2,695.80
2,008
Interest Expense
-
-
-
180.70
996.70
135.30
Pretax Income
628.50
2,131.40
1,318.50
2,077.90
3,689.30
2,120.80
Consolidated Net Income
628.50
2,131.40
1,318.50
2,077.90
3,689.30
2,120.80
Net Income
628.50
2,131.40
1,318.50
2,077.90
3,689.30
2,120.80
Net Income After Extraordinaries
224.30
2,131.40
1,318.50
2,077.90
3,689.30
2,120.80
Net Income Available to Common
628.50
2,131.40
1,318.50
2,077.90
3,689.30
2,120.80
EPS (Basic)
0.02
0.03
0.02
0.03
0.05
0.03
Basic Shares Outstanding
63,401.10
66,575.10
67,233.30
69,772.50
74,386.30
77,748.40
EPS (Diluted)
0.02
0.03
0.02
0.03
0.05
0.03
Diluted Shares Outstanding
63,401.10
66,575.10
67,233.30
69,772.50
74,386.30
77,748.40
EBITDA
628.50
2,131.40
1,318.50
1,898.20
2,695.50
2,007.70
Non-Operating Interest Income
-
-
-
1.00
3.10
22.50

About RenovaCare

View Profile
Address
94 Hundred Corporate Center
Scottsdale Arizona 85260
United States
Employees -
Website http://www.renovacareinc.com
Updated 07/08/2019
RenovaCare, Inc. operates as a development stage company. It focuses on the acquisition, research, development and, if warranted, commercialization of autologous cellular therapies that can be used for medical and aesthetic applications. The company was founded on July 14, 1983 and is headquartered in Pittsburgh, PA.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.